Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1993 2
1995 2
1996 3
2000 1
2003 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Arrhythmogenic potential of positive inotropic agents.
Stump GL, Wallace AA, Gilberto DB, Gehret JR, Lynch JJ Jr. Stump GL, et al. Among authors: gehret jr. Basic Res Cardiol. 2000 Jun;95(3):186-98. doi: 10.1007/s003950050181. Basic Res Cardiol. 2000. PMID: 10879620
Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
Wallace AA, Stupienski RF 3rd, Baskin EP, Appleby SD, Kothstein T, Gehret JR, King SW, Remy DC, Lynch JJ Jr. Wallace AA, et al. Among authors: gehret jr. J Pharmacol Exp Ther. 1995 Apr;273(1):168-75. J Pharmacol Exp Ther. 1995. PMID: 7714763
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
Cook JJ, Holahan MA, Lyle EA, Ramjit DR, Sitko GR, Stranieri MT, Stupienski RF 3rd, Wallace AA, Hand EL, Gehret JR, Kothstein T, Drag MD, McCormick GY, Perkins JJ, Ihle NC, Duggan ME, Hartman GD, Gould RJ, Lynch JJ Jr. Cook JJ, et al. Among authors: gehret jr. J Pharmacol Exp Ther. 1996 Jul;278(1):62-73. J Pharmacol Exp Ther. 1996. PMID: 8764336
Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ Jr, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC, et al. Lynch JJ Jr, et al. Among authors: gehret jr. J Pharmacol Exp Ther. 1993 May;265(2):720-30. J Pharmacol Exp Ther. 1993. PMID: 8496818
13 results